Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54 – Clinical Trial Not Allowed)
(RFA-CA-19-003)
National Cancer Institute
Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 – No Clinical Trial Allowed)
(RFA-CA-19-004)
National Cancer Institute
Deadline for both: December 17, 2018 (letters of intent due 30 days prior to deadline)
Filed Under: Funding Opportunities